Načítá se...
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
The benefit of adjuvant trastuzumab with chemotherapy in breast cancer is well-established; however, its impact on outcomes for older women with small, node-negative, human epidermal growth factor receptor 2-positive disease is less clear and unlikely to be addressed in prospective studies. This ret...
Uloženo v:
| Vydáno v: | Clin Breast Cancer |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575753/ https://ncbi.nlm.nih.gov/pubmed/27622751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2016.07.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|